This refresh
Data-driven refresh May 18, 2026. Top 5 per bucket by live Bull Rankings score across a 5181-ticker universe covering every US-listed common stock on NYSE, NASDAQ, NYSE American, and NYSE Arca (2510 passed the market-cap / liquidity screen). Fundamentals sourced from Yahoo Finance quoteSummary + quarterly FCF reconstruction; narrative from Gemini (with data-driven fallback). Intraday re-ranking from a top-30 per-bucket shortlist.
Growth — high-quality compounders
1. KGC — Kinross Gold Corporation · score 98
Gold · price $28.38 · 1Y $40.55 · 5Y $45.71 · 10Y $67.19
FCF $3.0b B · Rev +60.8% A · D/E 0.08 A · P/E 12.1x B+ · PEG 1.12 B+
Why now. Kinross Gold Corporation, a leading gold producer, sells gold to refineries, banks, and other financial institutions, with a current price of $28.38 and a P/E of 12.08. The company's 60.8% revenue growth rate and 35.99% profit margin are driving its growth, with a strong analyst consensus 1-yr target of $40.55. The company's growth is further supported by its FCF of $3.03B, which indicates a healthy cash flow generation.
Moat. Kinross Gold Corporation's durable competitive advantage lies in its 35.47% ROE, which is driven by its cost advantages in gold production, with a debt-to-equity ratio of 0.082. The company's ability to maintain a high ROE is attributed to its pricing power, which is a result of its significant market share in the gold production industry. Additionally, the company's profit margin of 35.99% indicates its ability to maintain high profitability.
Risk. The company faces risks from its high beta of 1.372, which indicates a high sensitivity to market volatility. Additionally, the company's P/E of 12.08 is relatively high compared to its peers, which may indicate a potential correction in the stock price. Furthermore, the company's debt-to-equity ratio of 0.082 may increase if the company takes on more debt to finance its operations, which could negatively impact its financial health.
Horizon. 1-3 yr $40.55 (analyst consensus (n=11)) — fundamentals + valuation re-rating. 5 yr $45.71 at ~10% CAGR — compounding case rests on the competitive position widening. 10 yr $67.19 if current growth sustains into durable earnings power.
2. PICS — PicS N.V. · score 96
Software - Infrastructure · price $10.50 · 1Y $22.16 · 5Y $16.91 · 10Y $24.86
FCF $167m C · Rev +68.7% A · D/E 0.41 B+ · P/E 6.3x A · PEG — —
Why now. PicS N.V., a software infrastructure company, is currently trading at a $10.50 price point with a 6.29 P/E ratio, indicating undervaluation. The company has demonstrated a 68.7% revenue growth rate over the past year, driven by its growth-oriented business model. With an analyst consensus 1-yr target of $22.16, the stock has potential for significant upside.
Moat. PicS N.V.'s durable competitive advantage stems from its ability to generate a 40.38% return on equity, driven by its 10.62% profit margin. The company's high ROE is a result of its pricing power, which is derived from its category leadership in the software infrastructure market. Additionally, the company's $167.11 million in free cash flow provides a cushion for investments in growth initiatives and shareholder returns.
Risk. The primary risks facing PicS N.V. include competition from established players, regulatory scrutiny, and the potential for debt-to-equity ratio to increase. The company's 0.41 debt-to-equity ratio is a concern, as it may limit the company's ability to invest in growth opportunities. Furthermore, the company's reliance on a few key customers and the potential for revenue deceleration are also risks that need to be monitored.
Horizon. 1-3 yr $22.16 (analyst consensus (n=9)) — fundamentals + valuation re-rating. 5 yr $16.91 at ~10% CAGR — compounding case rests on the competitive position widening. 10 yr $24.86 if current growth sustains into durable earnings power.
3. NEM — Newmont Corporation · score 95
Gold · price $109.06 · 1Y $144.01 · 5Y $175.64 · 10Y $258.18
FCF $9.2b B+ · Rev +45.8% A · D/E 0.16 A- · P/E 14.1x B+ · PEG 2.78 C
Why now. Newmont Corporation, a leading gold producer, is poised for growth driven by its 45.8% revenue growth rate and 33.87% profit margin, with a current price of $109.06. The company sells gold to various end-markets, including jewelry, technology, and investment sectors. The growth rate is driven by the company's strategic expansion and increasing demand for gold, with a strong free cash flow of $9.238 billion supporting its growth initiatives.
Moat. Newmont Corporation's durable competitive advantage stems from its 25.83% return on equity, driven by its pricing power as a category leader in the gold industry. The company's large market share and significant gold reserves provide a cost advantage, allowing it to maintain its profit margin. Additionally, its strong balance sheet and low debt-to-equity ratio of 0.1576 provide financial flexibility to invest in growth opportunities.
Risk. Newmont Corporation faces risks from competitors such as Barrick Gold and AngloGold Ashanti, as well as regulatory risks from agencies such as the EPA. The company's 0.448 beta indicates a relatively low volatility, but its 14.15 P/E ratio is slightly elevated, leaving room for potential multiple compression. Furthermore, the company's growth is sensitive to gold price fluctuations, which can impact its revenue and profitability.
Horizon. 1-3 yr $144.01 (analyst consensus (n=20)) — fundamentals + valuation re-rating. 5 yr $175.64 at ~10% CAGR — compounding case rests on the competitive position widening. 10 yr $258.18 if current growth sustains into durable earnings power.
4. DLO — DLocal Limited · score 95
Software - Infrastructure · price $11.01 · 1Y $17.65 · 5Y $17.73 · 10Y $26.06
FCF $379m C · Rev +54.9% A · D/E 0.20 A- · P/E 17.2x B+ · PEG — —
Why now. DLocal Limited, a software infrastructure company, currently trades at $11.01 with a 17.2x P/E and a 54.9% revenue growth rate, driven by its high-quality compounder business model. The company's 15.8% profit margin and $378.7M free cash flow demonstrate its ability to generate cash and drive growth. With an analyst consensus 1-yr target of $17.65, DLocal is poised for continued growth in the software infrastructure space, serving customers in various end markets.
Moat. DLocal's durable competitive advantage stems from its high 34.99% ROE, which is driven by its pricing power and category leadership in the software infrastructure space. The company's ability to maintain a 2.67x P/S ratio while growing revenue at a rapid pace is a testament to its strong market position and customer loyalty. Additionally, DLocal's 15.8% profit margin and high ROE suggest that the company has a significant cost advantage, allowing it to invest in growth initiatives while maintaining profitability.
Risk. DLocal faces risks from competitors such as Stripe and PayPal, which could potentially disrupt its business model. The company's 1.02 beta and 0.20 debt-to-equity ratio also pose risks, as they indicate a higher level of volatility and leverage. Furthermore, regulatory risks from bodies such as the SEC and FTC could impact DLocal's ability to operate and grow its business.
Horizon. 1-3 yr $17.65 (analyst consensus (n=10)) — fundamentals + valuation re-rating. 5 yr $17.73 at ~10% CAGR — compounding case rests on the competitive position widening. 10 yr $26.06 if current growth sustains into durable earnings power.
5. EXE — Expand Energy Corporation · score 94
Oil & Gas E&P · price $96.69 · 1Y $132.12 · 5Y $155.72 · 10Y $228.90
FCF $2.8b B · Rev +41.0% A · D/E 0.26 A- · P/E 7.2x A · PEG 24.03 D
Why now. Expand Energy Corporation is a growth stock with a current price of $96.69, trading at a P/E of 7.19 and a PEG ratio of 24.03, indicating high growth expectations. The company sells oil and gas products to various end markets, with a revenue growth rate of 41% year-over-year. This growth is driven by the company's ability to generate significant free cash flow, with $2.8 billion in FCF over the trailing twelve months.
Moat. Expand Energy Corporation's durable competitive advantage stems from its high return on equity of 17.57%, driven by its pricing power in the oil and gas market. The company's profit margin of 24.91% is also a key factor in its ability to generate high returns. Additionally, the company's low debt-to-equity ratio of 0.26 provides it with the financial flexibility to invest in its operations and pursue growth opportunities.
Risk. The main risks facing Expand Energy Corporation include the volatility of oil and gas prices, which can impact the company's revenue and profitability. The company also faces competition from other oil and gas producers, such as ExxonMobil and Chevron. Furthermore, the company's beta of 0.35 indicates that it is less volatile than the overall market, but still subject to market fluctuations.
Horizon. 1-3 yr $132.12 (analyst consensus (n=25)) — fundamentals + valuation re-rating. 5 yr $155.72 at ~10% CAGR — compounding case rests on the competitive position widening. 10 yr $228.90 if current growth sustains into durable earnings power.
Value — quality at a discount
1. PDD — PDD Holdings Inc. · score 102
Internet Retail · price $95.83 · 1Y $142.71 · 5Y $128.24 · 10Y $163.69
FCF $15.5b A- · Rev +12.0% B+ · D/E 0.01 A · P/E 9.9x A- · PEG 0.68 A-
Why now. PDD Holdings Inc., a leading e-commerce platform, is currently undervalued with a 9.86 P/E ratio and a 0.68 PEG ratio, indicating statistical cheapness. The company's 22.66% profit margin and 26.93% ROE suggest a strong ability to generate earnings. With an analyst consensus 1-yr target of $142.71, there is potential for re-rating driven by the company's 12% revenue growth rate and $15.53B free cash flow.
Moat. PDD's durable competitive advantage stems from its 22.66% profit margin, driven by pricing power from category leadership in e-commerce. The company's 26.93% ROE is attributed to its ability to generate high returns on equity, likely due to its strong market position and efficient operations. Additionally, PDD's 2.15 price-to-sales ratio suggests a cost advantage, allowing the company to maintain its market share and competitiveness.
Risk. PDD faces risks from competitors such as Alibaba and JD.com, which could potentially disrupt its market share. The company's 0.013 debt-to-equity ratio is relatively low, but any significant increase in debt could pose a risk to its financial stability. Furthermore, regulatory risks from the Chinese government could impact PDD's operations and profitability, particularly if there are changes to e-commerce regulations or antitrust laws.
Horizon. 1-3 yr $142.71 (analyst consensus (n=33)) — multiple re-rating thesis requires a catalyst. 5 yr $128.24 at ~6% CAGR — dividend + buyback compounding. 10 yr $163.69 if the moat survives secular pressure.
2. AU — AngloGold Ashanti plc · score 100
Gold · price $92.24 · 1Y $123.29 · 5Y $123.44 · 10Y $157.56
FCF $3.3b B · Rev +64.9% A · D/E 0.22 A- · P/E 13.5x B+ · PEG 0.78 A-
Why now. AngloGold Ashanti plc, a gold mining company, is undervalued with a current price of $92.24 and a P/E of 13.54, considering its 64.9% revenue growth rate and 31.11% profit margin. The company sells gold to various end-markets, including jewelry, technology, and investment sectors. The re-rating catalyst could be the analyst consensus 1-yr target of $123.29, which is driven by the company's strong financial performance and growth prospects.
Moat. AngloGold Ashanti's durable competitive advantage lies in its 42.97% ROE, driven by its pricing power from category leadership in the gold mining industry. The company's cost advantages, including its low debt-to-equity ratio of 0.22, enable it to maintain its profitability. Additionally, the company's unique distribution network and regulatory protection in certain jurisdictions contribute to its moat.
Risk. The company faces material risks, including competition from other gold mining companies such as Barrick Gold and Newmont Corporation. The beta of 0.62 indicates that the company's stock price is less volatile than the market, but still sensitive to market fluctuations. Furthermore, the company's debt-to-equity ratio of 0.22 is relatively low, but any increase in debt levels could pose a risk to the company's financial stability.
Horizon. 1-3 yr $123.29 (analyst consensus (n=7)) — multiple re-rating thesis requires a catalyst. 5 yr $123.44 at ~6% CAGR — dividend + buyback compounding. 10 yr $157.56 if the moat survives secular pressure.
3. ADBE — Adobe Inc. · score 98
Software - Application · price $247.60 · 1Y $327.28 · 5Y $331.34 · 10Y $422.94
FCF $10.3b A- · Rev +12.0% B+ · D/E 0.58 B+ · P/E 14.4x B+ · PEG 0.70 A-
Why now. Adobe Inc., a leading provider of software solutions to creative professionals, marketers, and enterprises, is currently trading at a $247.60 price point with a 14.43 P/E ratio, indicating undervaluation. The company's 12% revenue growth rate and $10.32B free cash flow suggest a strong financial foundation. With an analyst consensus 1-yr target of $327.28, there is potential for re-rating driven by the company's growth trajectory and margin expansion.
Moat. Adobe's durable competitive advantage stems from its category leadership in creative software, with products like Photoshop and Illustrator, which have high switching costs and network effects. The company's 58.77% ROE is driven by pricing power from its dominant market position, allowing it to maintain high profit margins. Additionally, Adobe's large customer base and extensive distribution network provide a significant barrier to entry for competitors.
Risk. Key risks for Adobe include competition from other software providers, such as Autodesk and Microsoft, which could potentially disrupt its market share. The company's 0.58 debt-to-equity ratio and 1.42 beta also indicate some level of financial and market risk. Furthermore, regulatory scrutiny from bodies like the FTC could impact Adobe's ability to pursue strategic acquisitions and expand its product offerings.
Horizon. 1-3 yr $327.28 (analyst consensus (n=34)) — multiple re-rating thesis requires a catalyst. 5 yr $331.34 at ~6% CAGR — dividend + buyback compounding. 10 yr $422.94 if the moat survives secular pressure.
4. BZ — Kanzhun Limited · score 98
Internet Content & Information · price $14.07 · 1Y $21.65 · 5Y $18.83 · 10Y $24.03
FCF $651m C+ · Rev +14.0% B+ · D/E 0.01 A · P/E 16.2x B+ · PEG 0.16 A
Why now. Kanzhun Limited, a leader in online recruitment services in China, is currently undervalued with a PEG ratio of 0.16 and a profit margin of 33.085%, indicating strong operational efficiency. The company's revenue growth rate of 14% and FCF of $651 million demonstrate its ability to generate cash and expand its business. With an analyst consensus 1-yr target of $21.65, the stock has significant upside potential.
Moat. Kanzhun's durable competitive advantage lies in its high ROE of 15.35%, driven by its pricing power and category leadership in the Chinese online recruitment market. The company's strong position in the market, with a significant user base and a wide range of job listings, creates a network effect that makes it difficult for competitors to enter or expand. Additionally, Kanzhun's low debt-to-equity ratio of 0.00787 provides financial flexibility to invest in growth initiatives.
Risk. The main risks facing Kanzhun include intense competition from other online recruitment platforms, such as LinkedIn and Indeed, which could lead to margin contraction. Additionally, regulatory changes in China, such as those imposed by the Cyberspace Administration of China (CAC), could impact the company's operations. Furthermore, Kanzhun's beta of 0.485 indicates that the stock may be less volatile than the overall market, but still poses some level of risk.
Horizon. 1-3 yr $21.65 (analyst consensus (n=21)) — multiple re-rating thesis requires a catalyst. 5 yr $18.83 at ~6% CAGR — dividend + buyback compounding. 10 yr $24.03 if the moat survives secular pressure.
5. INCY — Incyte Corporation · score 97
Biotechnology · price $95.31 · 1Y $108.50 · 5Y $127.55 · 10Y $162.80
FCF $1.4b C+ · Rev +20.9% A- · D/E 0.01 A · P/E 13.5x B+ · PEG 0.36 A
Why now. Incyte Corporation, a biotechnology company selling treatments for various diseases, including cancer and autoimmune disorders, to healthcare providers and patients in the pharmaceutical end market, is currently undervalued with a 13.46 P/E ratio and a 0.36 PEG ratio. The company's 20.9% revenue growth rate and 26.71% profit margin make it an attractive value investment. With an analyst consensus 1-yr target of $108.50, the stock has potential for re-rating.
Moat. Incyte's durable competitive advantage stems from its high return on equity (30.82%), driven by pricing power from its category leadership in certain pharmaceutical products. The company's strong product portfolio, including treatments for rare diseases, creates switching costs for customers and provides a cost advantage. Additionally, Incyte's regulatory protection and intellectual property rights for its products contribute to its moat.
Risk. The main risks for Incyte include competition from other biotechnology companies, such as Gilead Sciences and Bristol Myers Squibb, and regulatory risks from agencies like the FDA. The company's 0.007 debt-to-equity ratio is relatively low, but its 0.797 beta indicates some volatility. Furthermore, Incyte's reliance on a few key products for revenue growth poses a risk if any of these products experience significant declines in sales.
Horizon. 1-3 yr $108.50 (analyst consensus (n=22)) — multiple re-rating thesis requires a catalyst. 5 yr $127.55 at ~6% CAGR — dividend + buyback compounding. 10 yr $162.80 if the moat survives secular pressure.
Speculative — asymmetric upside
1. BILL — BILL Holdings, Inc. · score 87
Software - Application · price $40.07 · 1Y $55.14 · 5Y $80.60 · 10Y $209.72
FCF $327m C · Rev +13.5% B+ · D/E 0.50 B+ · P/S 2.5x A- · PEG 0.40 A
Why now. BILL Holdings, Inc., a software application company, is currently trading at $40.07 with a 13.5% revenue growth rate and a 0.4 PEG ratio, indicating a potentially undervalued growth story. The company's $55.14 analyst consensus 1-yr target suggests a significant upside. BILL sells software solutions to businesses, and its growth is driven by the increasing demand for digital payment and accounting solutions.
Moat. BILL's durable competitive advantage lies in its ability to generate $326.6M in free cash flow, which is being utilized to drive growth and expand its customer base. The company's 0.4959 debt-to-equity ratio and 1.223 beta indicate a moderate level of risk, but its 0.01% profit margin and 0.004% ROE suggest room for improvement. BILL's software solutions have a high switching cost, which helps to retain customers and drive recurring revenue.
Risk. BILL faces risks from competitors such as Intuit and Xero, which could potentially disrupt its growth trajectory. The company's 0.4959 debt-to-equity ratio and 1.223 beta also indicate a moderate level of risk. Additionally, regulatory changes in the accounting and payment processing industries could impact BILL's business. The company's 0.01% profit margin is also a concern, as it may not be sustainable in the long term.
Horizon. 1-3 yr $55.14 (analyst consensus (n=21)) — catalyst-driven; binary events dominate. 5 yr $80.60 — requires the platform / technology to reach commercial scale. 10 yr $209.72 — return distribution heavily skewed.
2. OMC — Omnicom Group Inc. · score 86
Advertising Agencies · price $70.83 · 1Y $99.80 · 5Y $142.46 · 10Y $370.71
FCF $3.0b B · Rev +69.2% A · D/E 1.11 C+ · P/S 1.0x A- · PEG 15.97 D
Why now. Omnicom Group Inc., a leading advertising agency, is poised for growth driven by its 69.2% revenue growth rate and $2.99B in free cash flow, with a 15.97 PEG ratio indicating potential for long-term growth. The company's current price of $70.83 and analyst consensus 1-yr target of $99.80 suggest a significant upside. As a high-risk, high-reward investment, OMC's success hinges on its ability to maintain its growth trajectory and navigate the competitive advertising landscape.
Moat. Omnicom's durable competitive advantage lies in its extensive network of advertising agencies and its ability to provide integrated marketing services to clients. With a 31.8% profit margin and a 2.015% ROE, the company has demonstrated its ability to generate profits and create value for shareholders. Additionally, its 1.01829 price-to-sales ratio suggests a reasonable valuation relative to its revenue.
Risk. Omnicom faces significant risks, including intense competition from other advertising agencies, a 1.10574 debt-to-equity ratio, and a 0.682 beta indicating moderate volatility. Furthermore, the company's reliance on a few large clients and its exposure to economic downturns pose additional risks. Regulatory changes and shifts in consumer behavior also pose threats to the company's business model.
Horizon. 1-3 yr $99.80 (analyst consensus (n=10)) — catalyst-driven; binary events dominate. 5 yr $142.46 — requires the platform / technology to reach commercial scale. 10 yr $370.71 — return distribution heavily skewed.
3. CRC — California Resources Corporation · score 83
Oil & Gas E&P · price $61.14 · 1Y $80.91 · 5Y $122.97 · 10Y $320.00
FCF $865m C+ · Rev +6.7% C+ · D/E 0.47 B+ · P/S 1.6x A- · PEG 0.29 A
Why now. California Resources Corporation, an oil and gas exploration and production company, is currently trading at $61.14 with a 6.7% revenue growth rate and a 0.29 PEG ratio, indicating a potential for high-risk, high-reward investment. The company's $865 million in free cash flow and a debt-to-equity ratio of 0.47224 suggest a manageable financial position. With an analyst consensus 1-yr target of $80.91, the stock has a potential upside driven by its growth prospects and improving financials.
Moat. California Resources Corporation's durable competitive advantage lies in its cost advantages and regulatory protection in the oil and gas industry. The company's 1.5672402 price-to-sales ratio and -13.366% profit margin suggest a competitive pricing environment, but its -14.392% return on equity indicates a need for improvement in operational efficiency. The company's unique distribution and cost advantages in the California market provide a moat against competitors.
Risk. The company faces material risks from its high debt-to-equity ratio of 0.47224 and a 0.957 beta, indicating a high sensitivity to market volatility. Additionally, the company's -13.366% profit margin and -14.392% return on equity suggest a need for improvement in operational efficiency to mitigate the risk of declining revenue and increasing costs. Competitors such as Chevron and ExxonMobil also pose a risk to California Resources Corporation's market share.
Horizon. 1-3 yr $80.91 (analyst consensus (n=11)) — catalyst-driven; binary events dominate. 5 yr $122.97 — requires the platform / technology to reach commercial scale. 10 yr $320.00 — return distribution heavily skewed.
4. JAZZ — Jazz Pharmaceuticals plc · score 83
Biotechnology · price $228.77 · 1Y $241.76 · 5Y $460.14 · 10Y $1,197
FCF $1.1b C+ · Rev +19.1% B+ · D/E 1.20 C+ · P/S 3.2x B · PEG 0.95 B+
Why now. Jazz Pharmaceuticals plc, a biotechnology company selling sleep and hematology/oncology products, is set up for growth with a 19.1% revenue growth rate and a $1.14B free cash flow, driven by its high-margin products and a 66.4% profit margin. The company's current price of $228.77 is below the analyst consensus 1-yr target, indicating potential for upside. With a 0.95 PEG ratio, the stock appears reasonably valued for its growth prospects.
Moat. Jazz Pharmaceuticals' durable competitive advantage stems from its high-margin products, such as those for sleep disorders, which contribute to its 67.6% ROE. The company's pricing power, driven by its category leadership in certain therapeutic areas, enables it to maintain high margins. Additionally, its regulatory protection and IP for certain products, such as those related to hematology/oncology, provide a barrier to entry for competitors.
Risk. Jazz Pharmaceuticals faces risks from competitors such as Biogen and Pfizer, which could impact its market share. The company's 1.20 debt-to-equity ratio is also a concern, as it may limit its ability to invest in new products or acquisitions. Furthermore, regulatory changes, such as those from the FDA, could affect the company's product approvals and sales.
Horizon. 1-3 yr $241.76 (analyst consensus (n=17)) — catalyst-driven; binary events dominate. 5 yr $460.14 — requires the platform / technology to reach commercial scale. 10 yr $1,197 — return distribution heavily skewed.
5. TEAM — Atlassian Corporation · score 83
Software - Application · price $87.46 · 1Y $143.51 · 5Y $175.91 · 10Y $457.75
FCF $1.2b C+ · Rev +31.7% A · D/E 1.41 C+ · P/S 3.6x B · PEG 0.67 A-
Why now. Atlassian Corporation, a software application company, sells products like Jira and Trello to teams and organizations, driving a 31.7% revenue growth rate. With a current price of $87.46 and an analyst consensus 1-yr target of $143.51, the setup is compelling for a high-risk, high-reward investment. The company's free cash flow of $1.2B and profit margin of -3.5% indicate a need for improvement in profitability, but the growth rate and analyst target suggest a potential for upside.
Moat. Atlassian's durable competitive advantage lies in its high-switching-cost products like Jira and Trello, which have a strong presence in the software development and project management markets. The company's -19.3% ROE is a concern, but its 3.6x price-to-sales ratio and $1.2B in free cash flow indicate a company with a strong financial foundation. Atlassian's products have a significant market share, with Jira being a leading project management tool, which provides a cost advantage and regulatory protection through its widespread adoption.
Risk. Atlassian faces risks from competitors like Microsoft and Salesforce, which could disrupt its market share. The company's debt-to-equity ratio of 1.41 and beta of 0.9 indicate a moderate level of risk. Additionally, the company's -3.5% profit margin is a concern, and any decline in revenue growth could negatively impact the stock price.
Horizon. 1-3 yr $143.51 (analyst consensus (n=31)) — catalyst-driven; binary events dominate. 5 yr $175.91 — requires the platform / technology to reach commercial scale. 10 yr $457.75 — return distribution heavily skewed.
Methodology footnote
Every pick on this list comes out of the same seven-grade quantitative model applied to every US-listed common stock with a market cap above $1B. Each pick's score breakdown is auditable from the home page — click the ticker on the rankings page to see exactly which grades and adjustments produced the number. Not investment advice. See terms for full disclosures.